SCHEMBL24834273

SCHEMBL24834273

C=CCOCc1ccccc1C(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ AKR1C3 P42330 1/20 0.43
▸ CYP19A1 P11511 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ LIG1 P18858 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ KEAP1 Q14145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22799778 0.86 CYP3A4 (0.50) CYP3A4L3MBTL1MAPTGAAALDH1A1
SCHEMBL7865177 0.85 L3MBTL1 (0.54) CYP3A4L3MBTL1AKR1C3CYP19A1MAPT
SCHEMBL4622029 0.81 L3MBTL1 (0.50) CYP3A4L3MBTL1AKR1C3CYP19A1MAPT
Benzophenone SCHEMBL11875971 0.80 ALDH1A1 (0.56) CYP3A4L3MBTL1MAPTGAAALDH1A1
SCHEMBL9358998 0.80 L3MBTL1 (0.52) CYP3A4L3MBTL1AKR1C3CYP19A1MAPT
SCHEMBL943893 0.79 AKR1C3 (0.50) L3MBTL1AKR1C3CYP19A1MAPTGAA
SCHEMBL170063 0.79 AKR1C3 (0.50) L3MBTL1AKR1C3CYP19A1MAPTGAA
SCHEMBL30560007 0.79 AKR1C3 (0.50) L3MBTL1AKR1C3CYP19A1MAPTGAA
SCHEMBL22799781 0.79 ALDH1A1 (0.51) CYP3A4GAAALDH1A1TSHRHSD17B10
SCHEMBL22799660 0.79 CYP3A4 (0.46) CYP3A4L3MBTL1MAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002409-A1 MACROCYCLIC FLU ENDONUCLEASE INHIBITORS JANSSEN BIOPHARMA INC (US) 2023-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002409-A1 MACROCYCLIC FLU ENDONUCLEASE INHIBITORS ACE, PNP, FEN1 CYP3A4 88/4885L3MBTL1 2124/4885AKR1C3 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback